Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005776
Filing Date
2025-08-13
Accepted
2025-08-13 16:29:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3879
  Complete submission text file 0001950047-25-005776.txt   5385
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Subject) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38938 | Film No.: 251212125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address
Allan Jonathan (Reporting) CIK: 0001966716 (see all company filings)

Type: 144